secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2022-12-13T23:59:59+00:00
Accession:  0001628280-22-031796
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology reports record Q2 revenue of $14.3M, cuts FY growth outlook to 10-15%
--------------------------------------------------------------------------------

- Record quarterly revenue of $14.3M, up 21% YoY from $11.8M.
- Adjusted EBITDA of $686K, down from $743K in prior-year period.
- Operating income just $7K; gross margin fell to 48% from 52%.
- Full-year growth target revised to 10%-15% due to increased cancellations and economic slowdown.
- Cash on hand $10.8M, no debt; cash from operations $3.3M for the quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828022031796/0001628280-22-031796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828022031796/csbr-20221213.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-031796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer